OBJECTIVE To estimate the cost of preparing cytostatic drugs in the intravenous preparation unit in a hospital in Mexico. METHOD The annual cost of preparing cytostatic drugs based on the information of 92 days, considering the costs of drugs, the mixing service (including standard solution, quality control, services and waste) and salaries were estimated. The costs are estimated in Mexican p...

background pegylated interferon alfa plus ribavirin protocol is currently considered the most efficient hepatitis c treatment. however, no evidence of costs comparison among common viral genotypes has been published. objectives we aimed to assess core drivers of hepatitis c medical care costs and compare cost effectiveness of this treatment among patients infected by hepatitis c virus with geno...

Regulatory agencies approve drugs for marketing when the ratio of risk to benefit of the drugs is positive, i.e. the potential benefit of using the drug justifies the risk of drug related adverse reactions (ADR). At the point of approval of a drug there is not adequate information about all possible negative outcomes arising from its use in clinical practice. The information is even more limite...